OlainFarm (Latvia)

Olainfarm is a leading manufacturer in the chemical and pharmaceutical sector of the Baltic States, with 45 years of experience. Their portfolio includes over 60 finished dosage forms (FDFs), 25 active pharmaceutical ingredients (APIs), and more than 20 intermediates. Olainfarm specializes in neurology, cardiology, infectology, and allergology.

With a strong technological foundation, Olainfarm excels in adamantane, quinuclidine, and nitrofurane chemistry. The company is certified according to EU GMP standards for APIs and FDFs, U.S. cGMP standards for certain APIs (FDA), and TGA standards for FDFs (Australia). Additionally, they hold CEP certifications for certain APIs and comply with ISO 14001 for environmental management and ISO 17025 for laboratory management.

Olainfarm’s reputation for high-quality products is supported by collaborations with renowned global and regional companies such as Novartis, Dr. Reddy’s, Glenmark Generics, Sigma AU, Almirall Ranke, UQUIFA, MIAT, Actavis, Teva, Egis, and PHF, among others. Since 2011, they have been supplying anti-tuberculosis medication to the World Health Organisation.

The company also holds a controlling stake in Silvanols, a leading Latvian food supplement company. They operate a pharmacy chain, Latvijas aptieka, in Latvia and own the elastic medical products manufacturer Tonus Elast, the natural herbal medicines and food supplements producer NPK Biotest (Belarus), the medical companies Klīnika DiaMed and Olainmed, and the eco-cosmetics company Kiwi Cosmetics.

Olainfarm has representative offices in multiple countries, including Russia, Ukraine, Belarus, Tajikistan, Albania, Armenia, Kazakhstan, Kosovo, Mongolia, Georgia, and Uzbekistan. They also have subsidiaries in Latvia, Belarus, Russia, Lithuania, Estonia, the Czech Republic, Turkey, Azerbaijan, and Kyrgyzstan, with contracted agents in the USA, Serbia, Turkmenistan, Moldova, Sweden, and Southeast Asia.

In 2017, Olainfarm’s consolidated sales reached 122.1 million euros, with a profit of 10.8 million euros, and export sales amounted to 91.58 million euros. The Olainfarm Group exports to over 60 countries, with exports making up nearly 75% of their sales. Their main export markets include Russia, Ukraine, Belarus, The Netherlands, Kazakhstan, Uzbekistan, and Germany, with Australia being their farthest market.

The company employs a highly professional team of over 1,000 people and operates a production area spanning 480,000 square meters, conveniently located with access to highways and an airport.